Impact of C reactive protein on effectiveness of interleukin-17 and tumour necrosis factor inhibitors in axial spondyloarthritis: a Danish nationwide observational study

Annemette Høegh Pedersen, Kasper Yde Jensen, Merete Lund Hetland, Bente Glintborg · 2026

Read Impact of C reactive protein on effectiveness of interleukin-17 and tumour necrosis factor inhibitors in axial spondyloarthritis: a Danish nationwide observational study by Annemette Høegh Pedersen, Kasper Yde Jensen, Merete Lund Hetland, Bente Glintborg (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13289413.txt.

Description

Annemette Høegh Pedersen and colleagues studied a 2026 Danish registry cohort. They asked whether inflammation at treatment start predicts success of two biologic classes in axial spondyloarthritis. That disease inflames the spine and pelvis joints. The marker tested was C reactive protein, a blood sign of inflammation, split into low, middle, and high bands.

The DANBIO registry held 3387 patients starting a first IL-17 blocker or first TNF blocker between 2015 and 2024. Staying on therapy at twelve months rose slightly with higher starting inflammation for TNF blockers, but not clearly for IL-17 blockers in the models. Remission by a standard activity score was also checked by band. Sex and X-ray status did not change the broad picture.

Catalog record

CREATORAnnemette Høegh Pedersen, Kasper Yde Jensen, Merete Lund Hetland, Bente Glintborg
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38781
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13289413

Browse the full library · About the Tower of Babel